Open AccessCritically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
Author(s) -
Idoia Busnadiego,
Irène A. Abela,
Pascal M. Frey,
Daniel A. Hofmaenner,
Thomas Scheier,
Reto A. Schuepbach,
Philipp K. Buehler,
Silvio D. Brugger,
Benjamin G. Hale
Publication year - 2022
Publication title -
plos biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.127
H-Index - 271
eISSN - 1545-7885
pISSN - 1544-9173
DOI - 10.1371/journal.pbio.3001709
Subject(s) - biology , covid-19 , autoantibody , virology , immunology , disease , critically ill , antibody , infectious disease (medical specialty) , intensive care medicine , medicine , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom